Browsing: Riding

Medytox’s (086900.KQ) fat-reduction injectable “Neubeauju” has achieved more than half of its annual revenue target within two months of launch, showing rapid growth. The trend reflects rising demand to improve double chins and skin sagging after weight loss, as glucagon-like peptide (GLP)-1 obesity treatments have become widespread. As interest grows in body contouring beyond simple…